An Intervention to Address Parental Smoking During the Postpartum Hospitalization. (NEWS)

This study has been completed.
Sponsor:
Collaborator:
Robert Wood Johnson Foundation
Information provided by:
Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00844818
First received: February 12, 2009
Last updated: NA
Last verified: February 2009
History: No changes posted
  Purpose

The purpose of the study is to find better ways to help parents quit smoking, thus improving their own health, the health of their children, and the health of other family members. This study tested the feasibility and acceptability of enrolling parents into a telephone quitline during postpartum hospitalization. Half of the parents in the study received quit smoking assistance (intervention group), and half of the parents did not (control group). The percentage of parental smokers who are enrolled in quit smoking programs by the study follow-up will be greater in the intervention group than in the control group.


Condition Intervention
Tobacco Use
Parental Smoking
Behavioral: Telephone Quitline Enrollment

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Using the Postpartum Hospital Stay to Address Mother's and Father's Smoking: the NEWS Study

Resource links provided by NLM:


Further study details as provided by Massachusetts General Hospital:

Enrollment: 101
Study Start Date: February 2005
Study Completion Date: April 2006
Primary Completion Date: April 2006 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control
Moms and dads who were current smokers (1 cigarette, even a puff, in past 30 days) or recent quitters (smoked since one month prior to conception)
Experimental: Intervention Group
Moms and dads who were current smokers (1 cigarette, even a puff, in past 30 days) or recent quitters (smoked since one month prior to conception)
Behavioral: Telephone Quitline Enrollment
The intervention included a brief motivational interview (MI), enrollment in the proactive state quitline, and follow-up faxes to the pediatric, OB, and PCP providers with tailored treatment messages.

Detailed Description:

This is a randomized control trial to test the feasibility and efficacy of modifying hospital staff practices on the postpartum floor and intervening with parents before hospital discharge to help them quit smoking. Over 14 months, we assessed the smoking status of both parents of all newborns delivered at 1 hospital. Moms and dads who were current smokers (1 cigarette, even a puff, in past 30 days) or recent quitters (smoked since one month prior to conception) were eligible for the study. Enrolled parents were randomly assigned to the control or intervention group. The intervention included a brief motivational interview (MI), enrollment in the proactive state quitline, and follow-up faxes to the pediatric, OB, and PCP providers with tailored treatment messages.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Parents of newborns delivered at MGH ("parent" includes the mother, father or another legal guardian) who are: a) current smokers (have smoked, even a puff, within the last 30 days and/or b) recent quitters (have smoked, even a puff, since 30 days prior to conception);
  • Telephone access;
  • English competency, adequate to participate in the interview;
  • Massachusetts resident for next 3 months (from date of consent).

Exclusion Criteria:

  • Non-smokers or parents who have not smoked since before one month prior to conception (cessation great than 10 months);
  • Non-English speaking;
  • Non-Massachusetts residents;
  • Any family with critically ill mother or infant that the obstetrical nurse practitioner does not feel is appropriate to be approached;
  • Decline participation.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00844818

Locations
United States, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Sponsors and Collaborators
Massachusetts General Hospital
Robert Wood Johnson Foundation
Investigators
Principal Investigator: Jonathan P Winickoff, MD, MPH Massachusetts General Hospital
  More Information

No publications provided

Responsible Party: Jonathan Winickoff, MD, MPH, Massachusetts General Hospital
ClinicalTrials.gov Identifier: NCT00844818     History of Changes
Other Study ID Numbers: 2004P002104
Study First Received: February 12, 2009
Last Updated: February 12, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Massachusetts General Hospital:
smoking cessation
parents

Additional relevant MeSH terms:
Tobacco Use Disorder
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on August 25, 2014